Your browser doesn't support javascript.
loading
Reporting of Cardiovascular Events in Clinical Trials Supporting FDA Approval of Contemporary Cancer Therapies.
Bonsu, Janice M; Guha, Avirup; Charles, Lawrence; Yildiz, Vedat O; Wei, Lai; Baker, Brandee; Brammer, Jonathan E; Awan, Farrukh; Lustberg, Maryam; Reinbolt, Raquel; Miller, Eric D; Jneid, Hani; Ruz, Patrick; Carter, Rebecca R; Milks, Michael W; Paskett, Electra D; Addison, Daniel.
Afiliação
  • Bonsu JM; Cardio-Oncology Program, Division of Cardiology, The Ohio State University Medical Center, Columbus, Ohio.
  • Guha A; Cardio-Oncology Program, Division of Cardiology, The Ohio State University Medical Center, Columbus, Ohio; Harrington Heart and Vascular Institute, Case Western Reserve University, Cleveland, Ohio.
  • Charles L; Cardio-Oncology Program, Division of Cardiology, The Ohio State University Medical Center, Columbus, Ohio.
  • Yildiz VO; Cardio-Oncology Program, Division of Cardiology, The Ohio State University Medical Center, Columbus, Ohio; Center for Biostatistics, Department of Biomedical Informatics, The Ohio State University, Columbus, Ohio.
  • Wei L; Cardio-Oncology Program, Division of Cardiology, The Ohio State University Medical Center, Columbus, Ohio; Center for Biostatistics, Department of Biomedical Informatics, The Ohio State University, Columbus, Ohio.
  • Baker B; Cardio-Oncology Program, Division of Cardiology, The Ohio State University Medical Center, Columbus, Ohio; Division of Cancer Prevention and Control, Department of Internal Medicine, College of Medicine, The Ohio State University, Columbus, Ohio.
  • Brammer JE; Division of Hematology, James Cancer Hospital and Solove Research Institute at The Ohio State University, Columbus, Ohio.
  • Awan F; Division of Hematology, James Cancer Hospital and Solove Research Institute at The Ohio State University, Columbus, Ohio; Division of Hematology, University of Texas-Southwestern Cancer Center, Dallas, Texas.
  • Lustberg M; Cardio-Oncology Program, Division of Cardiology, The Ohio State University Medical Center, Columbus, Ohio; Division of Medical Oncology, James Cancer Hospital and Solove Research Institute at The Ohio State University, Columbus, Ohio.
  • Reinbolt R; Division of Medical Oncology, James Cancer Hospital and Solove Research Institute at The Ohio State University, Columbus, Ohio.
  • Miller ED; Department of Radiation Oncology, James Cancer Hospital and Solove Research Institute at The Ohio State University, Columbus, Ohio.
  • Jneid H; Division of Cardiology, Baylor College of Medicine, Michael E. DeBakey VA Medical Center, Houston, Texas.
  • Ruz P; Cardio-Oncology Program, Division of Cardiology, The Ohio State University Medical Center, Columbus, Ohio.
  • Carter RR; Cardio-Oncology Program, Division of Cardiology, The Ohio State University Medical Center, Columbus, Ohio; Center for the Advancement of Team Science, Analytics, and Systems Thinking (CATALYST), Ohio State University College of Medicine, Columbus, Ohio.
  • Milks MW; Cardio-Oncology Program, Division of Cardiology, The Ohio State University Medical Center, Columbus, Ohio.
  • Paskett ED; Division of Cancer Prevention and Control, Department of Internal Medicine, College of Medicine, The Ohio State University, Columbus, Ohio.
  • Addison D; Cardio-Oncology Program, Division of Cardiology, The Ohio State University Medical Center, Columbus, Ohio; Division of Cancer Prevention and Control, Department of Internal Medicine, College of Medicine, The Ohio State University, Columbus, Ohio. Electronic address: daniel.addison@osumc.edu.
J Am Coll Cardiol ; 75(6): 620-628, 2020 02 18.
Article em En | MEDLINE | ID: mdl-32057377

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Gestão de Riscos / Doenças Cardiovasculares / Ensaios Clínicos como Assunto / Aprovação de Drogas / Antineoplásicos Tipo de estudo: Etiology_studies / Systematic_reviews Limite: Humans Idioma: En Revista: J Am Coll Cardiol Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Gestão de Riscos / Doenças Cardiovasculares / Ensaios Clínicos como Assunto / Aprovação de Drogas / Antineoplásicos Tipo de estudo: Etiology_studies / Systematic_reviews Limite: Humans Idioma: En Revista: J Am Coll Cardiol Ano de publicação: 2020 Tipo de documento: Article